Rohit Vashisht, PhD

Title(s)Professional Research, Computational Health Scienc
SchoolSchool of Medicine
Address550 16th Street, #2725
San Francisco CA 94158
Emailrohit.vashisht@ucsf.edu
PronounsHe/Him/His
ORCID ORCID Icon0000-0002-2938-7259 Additional info
vCardDownload vCard

Collapse Biography 
Collapse education and training
Stanford University, Palo Alto, CaliforniaData Scientist2019Biomedical Informatics; Immunity, Transplantation and Infection
Stanford University, Palo Alto, CaliforniaPost-Doctoral Fellow2018Biomedical Informatics
Academy of Scientific and Innovative Research, New Delhi, IndiaPhD2015Data-Intensive Systems Level Analysis of Mycobacterium tuberculosis Genome for Drug Discovery
Indian Institute of Science, Bangalore, IndiaResearch Fellow2010Systems Biology of Mycobacterium Tuberculosis
Acharya Institute of Technology, Bangalore, IndiaBachelor of Engineering in Biotechnology2007Biotechnology
Collapse awards and honors
U.S. Food & Drug Administration Office of Women's Health2021UCSF-Stanford CERSI Grant
U.S. Food & Drug Administration, Center for Biologics Evaluation and Research2022UCSF-Stanford CERSI Grant
U.S. Food & Drug Administration, CBER, Office of Biostatistics and Pharmacovigilance2022UCSF-Stanford CERSI Grant
U.S. Food & Drug Administration Oncology Center of Excellence2024UCSF-Stanford CERSI Grant

Collapse Overview 
Collapse overview
Rohit Vashisht, PhD

Rohit Vashisht is a clinical data scientist in the Butte lab affiliated with the Bakar Computational Health Sciences Institute at the University of California, San Francisco. His research focuses on generating meaningful real-world evidence using statistical and machine learning methods, as well as causal inference, to support medical- and policy-level decision-making. Rohit earned his Ph.D. in biomedical science from the Academy of Scientific and Innovative Research in New Delhi, India, and his Bachelor of Engineering in Biotechnology from Acharya Institute of Technology in Bangalore, India. He completed his post-doctoral work at Stanford University.
Collapse media links

Collapse ORNG Applications 
Collapse Featured Publications

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Real-World Type 2 Diabetes Second-Line Treatment Allocation Among Patients. medRxiv. 2025 Mar 28. Davidson J, Vashisht R, Radtke K, Patel A, Koliwad SK, Butte AJ. PMID: 40196266; PMCID: PMC11974982.
    View in: PubMed   Mentions:
  2. Characterisation of digital therapeutic clinical trials: a systematic review with natural language processing. Lancet Digit Health. 2024 03; 6(3):e222-e229. Miao BY, Sushil M, Xu A, Wang M, Arneson D, Berkley E, Subash M, Vashisht R, Rudrapatna V, Butte AJ. PMID: 38395542; PMCID: PMC11074920.
    View in: PubMed   Mentions: 4     Fields:    
  3. Second-Line Pharmaceutical Treatments for Patients with Type 2 Diabetes. JAMA Netw Open. 2023 10 02; 6(10):e2336613. Vashisht R, Patel A, Dahm L, Han C, Medders KE, Mowers R, Byington CL, Koliwad SK, Butte AJ. PMID: 37782497; PMCID: PMC10546239.
    View in: PubMed   Mentions: 3     Fields:    Translation:Humans
  4. Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study. EClinicalMedicine. 2023 Apr; 58:101932. Voss EA, Shoaibi A, Yin Hui Lai L, Blacketer C, Alshammari T, Makadia R, Haynes K, Sena AG, Rao G, van Sandijk S, Fraboulet C, Boyer L, Le Carrour T, Horban S, Morales DR, Martínez Roldán J, Ramírez-Anguita JM, Mayer MA, de Wilde M, John LH, Duarte-Salles T, Roel E, Pistillo A, Kolde R, Maljkovic F, Denaxas S, Papez V, Kahn MG, Natarajan K, Reich C, Secora A, Minty EP, Shah NH, Posada JD, Garcia Morales MT, Bosca D, Cadenas Juanino H, Diaz Holgado A, Pedrera Jiménez M, Serrano Balazote P, García Barrio N, Sen S, Üresin AY, Erdogan B, Belmans L, Byttebier G, Malbrain MLNG, Dedman DJ, Cuccu Z, Vashisht R, Butte AJ, Patel A, Dahm L, Han C, Bu F, Arshad F, Ostropolets A, Nyberg F, Hripcsak G, Suchard MA, Prieto-Alhambra D, Rijnbeek PR, Schuemie MJ, Ryan PB. PMID: 37034358; PMCID: PMC10072853.
    View in: PubMed   Mentions: 3  
  5. Real-world utilization of SARS-CoV-2 serological testing in RNA positive patients across the United States. PLoS One. 2023; 18(2):e0281365. Rodriguez-Watson CV, Sheils NE, Louder AM, Eldridge EH, Lin ND, Pollock BD, Gatz JL, Grannis SJ, Vashisht R, Ghauri K, Valo G, Chakravarty AG, Lasky T, Jung M, Lovell SL, Major JM, Kabelac C, Knepper C, Leonard S, Embi PJ, Jenkinson WG, Klesh R, Garner OB, Patel A, Dahm L, Barin A, Cooper DM, Andriola T, Byington CL, Crews BO, Butte AJ, Allen J. PMID: 36763574; PMCID: PMC9916659.
    View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
  6. Real-world performance of SARS-Cov-2 serology tests in the United States, 2020. PLoS One. 2023; 18(2):e0279956. Rodriguez-Watson CV, Louder AM, Kabelac C, Frederick CM, Sheils NE, Eldridge EH, Lin ND, Pollock BD, Gatz JL, Grannis SJ, Vashisht R, Ghauri K, Knepper C, Leonard S, Embi PJ, Jenkinson G, Klesh R, Garner OB, Patel A, Dahm L, Barin A, Cooper DM, Andriola T, Byington CL, Crews BO, Butte AJ, Allen J. PMID: 36735683; PMCID: PMC9897562.
    View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
  7. Toward a causal model of chronic back pain: Challenges and opportunities. Front Comput Neurosci. 2022; 16:1017412. Huie JR, Vashisht R, Galivanche A, Hadjadj C, Morshed S, Butte AJ, Ferguson AR, O'Neill C. PMID: 36714527; PMCID: PMC9874096.
    View in: PubMed   Mentions: 5  
  8. From Genes to Geography, from Cells to Community, from Biomolecules to Behaviors: The Importance of Social Determinants of Health. Biomolecules. 2022 10 09; 12(10). Davidson J, Vashisht R, Butte AJ. PMID: 36291658; PMCID: PMC9599320.
    View in: PubMed   Mentions: 5     Fields:    Translation:Humans
  9. Androgen-deprivation therapy and SARS-CoV-2 in men with prostate cancer: findings from the University of California Health System registry. Ann Oncol. 2021 05; 32(5):678-679. Kwon DH, Vashisht R, Borno HT, Aggarwal RR, Small EJ, Butte AJ, Huang FW. PMID: 33571636; PMCID: PMC7870099.
    View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
  10. Age- and Sex-Associated Variations in the Sensitivity of Serological Tests Among Individuals Infected With SARS-CoV-2. JAMA Netw Open. 2021 02 01; 4(2):e210337. Vashisht R, Patel A, Crews BO, Garner OB, Dahm L, Wilson C, Butte AJ. PMID: 33576815; PMCID: PMC7881354.
    View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
  11. Identification of antiviral antihistamines for COVID-19 repurposing. Biochem Biophys Res Commun. 2021 01 29; 538:173-179. Reznikov LR, Norris MH, Vashisht R, Bluhm AP, Li D, Liao YJ, Brown A, Butte AJ, Ostrov DA. PMID: 33309272; PMCID: PMC7713548.
    View in: PubMed   Mentions: 49     Fields:    Translation:HumansAnimalsCells
  12. CovidCounties is an interactive real time tracker of the COVID19 pandemic at the level of US counties. Sci Data. 2020 11 16; 7(1):405. Arneson D, Elliott M, Mosenia A, Oskotsky B, Solodar S, Vashisht R, Zack T, Bleicher P, Butte AJ, Rudrapatna VA. PMID: 33199721; PMCID: PMC7669883.
    View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsPHPublic Health
  13. Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis. Sci Rep. 2020 07 06; 10(1):11115. Kim Y, Tian Y, Yang J, Huser V, Jin P, Lambert CG, Park H, You SC, Park RW, Rijnbeek PR, Van Zandt M, Reich C, Vashisht R, Wu Y, Duke J, Hripcsak G, Madigan D, Shah NH, Ryan PB, Schuemie MJ, Suchard MA. PMID: 32632237; PMCID: PMC7338498.
    View in: PubMed   Mentions: 11     Fields:    Translation:Humans
  14. Treatment Patterns for Chronic Comorbid Conditions in Patients With Cancer Using a Large-Scale Observational Data Network. JCO Clin Cancer Inform. 2020 03; 4:171-183. Chen R, Ryan P, Natarajan K, Falconer T, Crew KD, Reich CG, Vashisht R, Randhawa G, Shah NH, Hripcsak G. PMID: 32134687; PMCID: PMC7113074.
    View in: PubMed   Mentions: 11     Fields:    Translation:Humans
  15. Development and validation of a prognostic model predicting symptomatic hemorrhagic transformation in acute ischemic stroke at scale in the OHDSI network. PLoS One. 2020; 15(1):e0226718. Wang Q, Reps JM, Kostka KF, Ryan PB, Zou Y, Voss EA, Rijnbeek PR, Chen R, Rao GA, Morgan Stewart H, Williams AE, Williams RD, Van Zandt M, Falconer T, Fernandez-Chas M, Vashisht R, Pfohl SR, Shah NH, Kasthurirathne SN, You SC, Jiang Q, Reich C, Zhou Y. PMID: 31910437; PMCID: PMC6946584.
    View in: PubMed   Mentions: 17     Fields:    Translation:Humans
  16. Host-response-based gene signatures for tuberculosis diagnosis: A systematic comparison of 16 signatures. PLoS Med. 2019 04; 16(4):e1002786. Warsinske H, Vashisht R, Khatri P. PMID: 31013272; PMCID: PMC6478271.
    View in: PubMed   Mentions: 89     Fields:    Translation:HumansCells
  17. Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin: Analysis From the Observational Health Data Sciences and Informatics Initiative. JAMA Netw Open. 2018 08 03; 1(4):e181755. Vashisht R, Jung K, Schuler A, Banda JM, Park RW, Jin S, Li L, Dudley JT, Johnson KW, Shervey MM, Xu H, Wu Y, Natrajan K, Hripcsak G, Jin P, Van Zandt M, Reckard A, Reich CG, Weaver J, Schuemie MJ, Ryan PB, Callahan A, Shah NH. PMID: 30646124; PMCID: PMC6324274.
    View in: PubMed   Mentions: 30     Fields:    Translation:Humans
  18. Impact of integrated psycho-socio-economic support on treatment outcome in drug resistant tuberculosis - A retrospective cohort study. Indian J Tuberc. 2019 Jan; 66(1):105-110. Bhatt R, Chopra K, Vashisht R. PMID: 30797265.
    View in: PubMed   Mentions: 10     Fields:    Translation:Humans
  19. Learning Effective Treatment Pathways for Type-2 Diabetes from a clinical data warehouse. AMIA Annu Symp Proc. 2016; 2016:2036-2042. Vashisht R, Jung K, Shah N. PMID: 28269963; PMCID: PMC5333256.
    View in: PubMed   Mentions: 4     Fields:    Translation:Humans
  20. Metformin as a potential combination therapy with existing front-line antibiotics for Tuberculosis. J Transl Med. 2015 Mar 07; 13:83. Vashisht R, Brahmachari SK. PMID: 25880846; PMCID: PMC4359515.
    View in: PubMed   Mentions: 25     Fields:    Translation:Humans
  21. Systems level mapping of metabolic complexity in Mycobacterium tuberculosis to identify high-value drug targets. J Transl Med. 2014 Oct 11; 12:263. Vashisht R, Bhat AG, Kushwaha S, Bhardwaj A, OSDD Consortium, Brahmachari SK. PMID: 25304862; PMCID: PMC4201925.
    View in: PubMed   Mentions: 12     Fields:    Translation:Cells
  22. Social networks to biological networks: systems biology of Mycobacterium tuberculosis. Mol Biosyst. 2013 Jul; 9(7):1584-93. Vashisht R, Bhardwaj A, Brahmachari SK. PMID: 23629487.
    View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
  23. Crowd sourcing a new paradigm for interactome driven drug target identification in Mycobacterium tuberculosis. PLoS One. 2012; 7(7):e39808. Vashisht R, Mondal AK, Jain A, Shah A, Vishnoi P, Priyadarshini P, Bhattacharyya K, Rohira H, Bhat AG, Passi A, Mukherjee K, Choudhary KS, Kumar V, Arora A, Munusamy P, Subramanian A, Venkatachalam A, Gayathri S, Raj S, Chitra V, Verma K, Zaheer S, Balaganesh J, Gurusamy M, Razeeth M, Raja I, Thandapani M, Mevada V, Soni R, Rana S, Ramanna GM, Raghavan S, Subramanya SN, Kholia T, Patel R, Bhavnani V, Chiranjeevi L, Sengupta S, Singh PK, Atray N, Gandhi S, Avasthi TS, Nisthar S, Anurag M, Sharma P, Hasija Y, Dash D, Sharma A, Scaria V, Thomas Z, OSDD Consortium, Chandra N, Brahmachari SK, Bhardwaj A. PMID: 22808064; PMCID: PMC3395720.
    View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
  24. Modeling metabolic adjustment in Mycobacterium tuberculosis upon treatment with isoniazid. Syst Synth Biol. 2010 Dec; 4(4):299-309. Bhat AG, Vashisht R, Chandra N. PMID: 22132057; PMCID: PMC3065594.
    View in: PubMed   Mentions: 5  
  25. Protein-protein interaction networks suggest different targets have different propensities for triggering drug resistance. Syst Synth Biol. 2010 Dec; 4(4):311-22. Padiadpu J, Vashisht R, Chandra N. PMID: 22132058; PMCID: PMC3065591.
    View in: PubMed   Mentions: 11  
  26. Strategies for efficient disruption of metabolism in Mycobacterium tuberculosis from network analysis. Mol Biosyst. 2009 Dec; 5(12):1740-51. Raman K, Vashisht R, Chandra N. PMID: 19593474.
    View in: PubMed   Mentions: 8     Fields:    Translation:Cells
Rohit's Networks
Concepts (131)
Derived automatically from this person's publications.
Explore
_
Co-Authors (18)
People in Profiles who have published with this person.
Explore
_
Similar People (60)
People who share similar concepts with this person.
Explore
_
Same Department
Search Department
_

UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB03.

Copyright ©2025 The Regents of the University of California.